News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Justin Stebbing: Activity of botensilimab/balstilimab in patients with metastatic colon cancer
Jun 16, 2024, 02:00

Justin Stebbing: Activity of botensilimab/balstilimab in patients with metastatic colon cancer

Justin Stebbing shared a post on LinkedIn:

“Really interesting paper out today am part of in Nature Medicine showing activity of botensilimab/balstilimab, a new immunotherapy combination, in heavily pre-treated patients with metastatic colon cancer. Thanks to everyone involved, and all the patients.”

Read further.
Source: Justin Stebbing/LinkedIn 

Justin Stebbing is a visiting Professor of Cancer Medicine and Oncology at Imperial College, London and a Professor of Biomedical Sciences at Anglia Ruskin University (ARU), Cambridge. He was appointed the first NIHR oncology professor in 2011. He is editor-in-chief of Nature’s cancer journal Oncogene. Prof. Stebbing has published over 700 peer-reviewed papers in leading academic journals. He is a member of the American Society for Clinical Investigation, a fellow of the Royal College of Physicians, and the Royal College of Pathologists, and sits on many advisory boards. He is on the Editorial Board of OncoDaily.

Agustin Pimentel Andrea J. Bullock Ani S. Balmanoukian Anthony B. El-Khoueiry Apostolia M Tsimberidou Benjamin L. Schlechter Breelyn A. Wilky Bruno Bockorny cancer Chloe Delepine Daruka Mahadevan Dhan Chand Gabriel Mednick Gary K. Schwartz Ghassan K. Abou-Alfa Heinz Josef Lenz Jaymin M. Patel Joseph E. Grossman Justin C. Moser Justin Stebbing Katherine Rosenthal Marwan G. Fakih metastatic colon cancer Michael S. Gordon Nature Medicine Neil H. Segal OncoDaily Oncology Rachel E. Sanborn Steven J. O’Day Sunil Sharma Tyler J. Curiel Wei Wu
Special Coverage
Blog
Dec 21, 2024, 14:10
Arif Kamal: Ensuring all people have access to the cancer navigation services that will help them live more and better days
Blog
Dec 21, 2024, 14:06
The Accelerate 2025 Annual Conference Agenda Is Here!
Blog
Dec 21, 2024, 14:03
Pioneer the future of discovery and innovation with a fully funded Bicentenary PhD Studentship at The University of Manchester
Blog
Dec 21, 2024, 14:00
NCI Division of Cancer Prevention - DHT Derived Biomarkers and COAs for Remote Monitoring and Endpoint Development
Blog
Dec 21, 2024, 13:51
The ESMO President Letter emphasises the importance of collective action to shape the future of oncology
Blog
Dec 21, 2024, 13:48
Overcoming recurrence: How research is bringing new hope for breast cancer patients - The Institute of Cancer Research
Blog
Dec 21, 2024, 13:46
IARC - Cancer Incidence in Five Continents, Vol XII
Blog
Dec 21, 2024, 13:43
National University Cancer Institute, Singapore clinicians had the exciting opportunity to present their work at the ESMO Asia 2024
Blog
Dec 21, 2024, 13:40
UICC - Welcoming the newest member, The World Hepatitis Alliance
Blog
Dec 21, 2024, 13:35
Pediatric Cancer and Blood Disorders Center of Armenia - Prioritizing the continuous education and knowledge exchange of the medical staff
Blog
Dec 21, 2024, 13:33
SIOP Europe - International Childhood Cancer Day 2025
Blog
Dec 21, 2024, 13:29
Canadian Cancer Society - How 5 organizations are working to take on cancer’s biggest issues